UCL nanotechnology receives plaudits in Texas
31 October 2006
Endomagnetics Inc, a nanotechnology company that started life as a research project at UCL, has been praised by Prince Andrew, the Duke of York, in a speech in Texas.
The Duke, who is the Government's Special Representative for International Trade and Investment, was speaking to about 1000 delegates at Nano-TX, a major nanotechnology trade fair. He said: "Innovation in nanotechnology holds great promise, not only for business, but also for transforming people's lives for the better. Nanotechnology's potential is seemingly limitless, with applications that may save or prolong life, reduce poverty and hunger, and potentially address some of the burgeoning issues the world faces today, such as energy supply.
"At this conference, there is an exciting example of the early stages of this kind of progress. I speak of Endomagnetics, which was developed from research funded by the UK-Texas Bioscience Collaboration Initiative at University College London and the University of Houston.
"The partnership has resulted in a technology used to locate lymph nodes for the staging and treatment of various forms of cancer, including breast cancers and melanomas."
Professor Quentin Pankhurst, Deputy Director of the London Centre for Nanotechnology (LCN), who was at Nano-TX representing Endomagnetics, said: "The Duke of York's enthusiastic response is typical of the support we have received all over the world. People can see that we are making real progress in improving cancer treatment through the safe application of nanotechnology, and they appreciate that. Endomagnetics is just the first spinout company to come from the new LCN - and there is much more to come."
Image: HRH Prince Andrew, the Duke of York (left) with Professor Quentin Pankhurst at Nano-TX (copyright Bill Caruth)